Toll‐Like Receptor 4 Exacerbates Mycoplasma pneumoniaevia Promoting Transcription Factor EB‐Mediated Autophagy

Yan Liu, Jing Li, Xianfeng Lu, Shuangping Zhen, Jing HuoContrast 2022 · DOI

TL;DR

This study reveals that Toll-like Receptor 4 (TLR4) exacerbates Mycoplasma pneumoniae (M. pneumoniae) infections by promoting an inflammatory response and autophagy, mediated by the transcription factor EB (TFEB). Targeting the TLR4-TFEB axis could offer a novel therapeutic strategy for M. pneumoniae-induced pneumonia.

What Problem Does This Paper Address?

Community-acquired pneumonia, often caused by Mycoplasma pneumoniae, is a significant public health concern, especially with rising antibiotic resistance. While M. pneumoniae infections can be self-limiting, they can lead to severe complications like asthma exacerbations and chronic airway diseases. The underlying mechanisms by which M. pneumoniae triggers detrimental immune responses and cellular processes like autophagy are not fully understood. Specifically, the role of Toll-like Receptor 4 (TLR4), a key component of the innate immune system, in exacerbating M. pneumoniae infection and its downstream effects, remained unclear. This paper aims to elucidate the specific role of TLR4 in M. pneumoniae pathogenesis and identify the molecular pathways involved.

Methods

The researchers employed a multi-pronged approach to investigate TLR4's role:

  • In vivo studies: Wild-type and TLR4-deficient mice were infected with M. pneumoniae. Lung tissues were analyzed using Hematoxylin and Eosin (HE) staining to assess histological damage.
  • In vitro cell culture: Macrophage cell lines (RAW264.7) were used to study cellular responses.
  • Molecular techniques:
    • Western Blot: Used to quantify protein expression levels of key molecules like TLR4, TFEB, LC3 I/II (an autophagy marker), p62, Beclin-1, and ULK1.
  • ELISA (Enzyme-Linked Immunosorbent Assay): Employed to measure the levels of pro-inflammatory cytokines such as TNF-α and IL-1β.
  • Immunofluorescence Assay: Utilized to visualize the cellular localization of TFEB and LC3 puncta, indicating TFEB nuclear translocation and autophagosome formation, respectively.
  • siRNA (small interfering RNA) transfection: Used to specifically knock down TLR4 expression in cells.
  • Pharmacological inhibitors: TAK-242 (TLR4 inhibitor), CCI-779 (TFEB inhibitor), and chloroquine (CQ, an autophagy inhibitor) were used to probe specific pathways.

Datasets

Not discussed in the paper. The study primarily relies on experimental data generated from animal models and cell cultures.

Key Insights and Ideas

  • TLR4 is a key driver of M. pneumoniae pathology: The study strongly suggests that TLR4 is not just a bystander but actively contributes to the severity of M. pneumoniae infection.
  • TLR4 promotes inflammation and autophagy: The research demonstrates a dual role for TLR4, linking it to both the inflammatory cascade and the induction of autophagy, a cellular self-eating process that can be hijacked by pathogens.
  • TFEB acts as a crucial mediator: The transcription factor EB (TFEB) emerges as a central player, bridging TLR4 activation to both inflammation and autophagy. Its translocation to the nucleus appears to be a critical step.
  • A positive feedback loop: The findings suggest a potential positive feedback loop where TLR4 activation leads to TFEB activation, which in turn promotes inflammation and autophagy, further exacerbating the infection. This creates a self-sustaining cycle of damage.
  • Therapeutic implications: The identification of the TLR4-TFEB axis opens up new avenues for therapeutic intervention, potentially by inhibiting either TLR4 or TFEB to mitigate the damaging effects of M. pneumoniae.

Key Results

  • Protection in TLR4-deficient mice: Mice lacking TLR4 showed significantly reduced lung tissue damage after M. pneumoniae infection, indicating TLR4's detrimental role in vivo.
  • Increased pro-inflammatory cytokines: M. pneumoniae infection led to a dose-dependent increase in TNF-α and IL-1β levels in macrophages. Knockdown of TLR4 significantly reduced these cytokine levels.
  • Autophagy induction: M. pneumoniae infection upregulated autophagy markers (LC3 puncta, LC3 II, Beclin-1, Atg5) in macrophages. This induction was suppressed by a TLR4 inhibitor (TAK-242).
  • TFEB activation and nuclear translocation: M. pneumoniae promoted the translocation of TFEB from the cytoplasm to the nucleus, an effect reversed by TAK-242. Inhibition of TFEB with CCI-779 reduced TNF-α and IL-1β release.
  • TFEB's role in autophagy: Inhibition of TFEB (using CCI-779) and autophagy (using 3-MA) partially reversed the effects of M. pneumoniae, further solidifying TFEB's role in mediating autophagy.

Limitations and Future Work

  • Limitations:
    • The study primarily used a single strain of M. pneumoniae (M129) and a specific macrophage cell line (RAW264.7). Further studies with different strains and primary human cells would enhance generalizability.
  • While the TLR4-TFEB axis is implicated, the precise molecular interactions and signaling cascades within this loop require deeper investigation.
  • The study was conducted in a mouse model, and direct translation to human clinical outcomes needs further validation.
  • Future Work:
    • Investigate the specific mechanisms by which M. pneumoniae activates TLR4.
  • Explore the detailed downstream signaling pathways activated by TFEB in response to M. pneumoniae.
  • Develop and test specific inhibitors targeting the TLR4-TFEB axis for therapeutic efficacy in preclinical models of M. pneumoniae pneumonia.
  • Examine the role of this pathway in other TLR-mediated inflammatory diseases, potentially drawing parallels with conditions like COVID-19.

Summary updated

Abstract

<i>Mycoplasma pneumoniae</i> (<i>M. pneumoniae</i>) is the most common cause of community-acquired pneumonia. Toll-like receptors (TLRs) play an essential role in pneumonia. The purpose of this study was to investigate the roles of TLR4 in <i>M. pneumoniae</i>. Mice were administrated with 100 <i>μ</i>l (1 × 107 ccu/ml) of <i>M. pneumoniae</i>. HE staining was applied for histological analysis. The protein expression was determined by western blot. The cytokine level was detected by ELISA. The results showed that TLR4-deficient mice were protected from <i>M. pneumoniae</i>. However, downregulation of TLR4 inhibited inflammatory response and autophagy. Moreover, transcription factor EB (TFEB) participated in <i>M. pneumoniae</i>-induced inflammatory response and autophagy, while knockdown of TLR4 downregulated TFEB and its nuclear translocation.
BibTeX
@inproceedings{liu2022tolllike,
  author = {Yan Liu and Jing Li and Xianfeng Lu and Shuangping Zhen and Jing Huo},
  title = {{Toll‐Like Receptor 4 Exacerbates <i>Mycoplasma pneumoniae</i>via Promoting Transcription Factor EB‐Mediated Autophagy}},
  booktitle = {Contrast},
  year = {2022},
  doi = {10.1155/2022/3357694},
}
Figure